Home / News / FAQ
FAQ

Understanding Benign Brain Tumors in Women: Key Facts and FAQs

FaqStaq News - Just the FAQs August 14, 2025
By FAQstaq Staff
Read Original Article →
Understanding Benign Brain Tumors in Women: Key Facts and FAQs

Summary

Women are disproportionately affected by benign brain tumors, making up 62.9% of cases, highlighting the importance of recognizing symptoms and understanding treatment options.

What percentage of people who develop noncancerous brain tumors are women?

Women make up 62.9% of people who develop noncancerous brain tumors.

What are common symptoms of benign brain tumors that women should not ignore?

Common symptoms include forgetfulness and headaches, which are often mistakenly attributed to stress.

What is the primary treatment option for benign brain tumors?

Surgery to remove the benign tumor is the go-to treatment option.

Are there companies working on treatments for brain tumors?

Yes, companies like CNS Pharmaceuticals Inc. (NASDAQ: CNSP) are working to bring new treatments to market.

Where can I find the latest news and updates about CNS Pharmaceuticals Inc.?

The latest news and updates are available in the company’s newsroom at https://ibn.fm/CNSP.

What is BioMedWire and what does it offer?

BioMedWire is a specialized communications platform focusing on Biotechnology, Biomedical Sciences, and Life Sciences, offering access to a vast network of wire solutions, article and editorial syndication, press release enhancement, social media distribution, and tailored corporate communications solutions.

How can I receive SMS alerts from BioMedWire?

To receive SMS alerts, text ‘Biotech’ to 888-902-4192 (U.S. Mobile Phones Only).

Where can I find more information about BioMedWire?

For more information, visit https://www.BioMedWire.com.

QR Code for Content Provenance

This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)

Article Control ID: 150243